Thought it was worth revisiting this comparison seeing as though...

Thought it was worth revisiting this comparison seeing as though HVT is 'flying' at the moment. Here's a recap of approximately 18 months ago...

THC Biomed - 113.85m
Supreme Pharmaceuticals -270.79m
Pharmacan Capital Corp. - 197.98m
Organigram Holdings - 289.25m
Mettrum Health Corp. - 272.66m
Maple Leaf Green World - 78.49m
Golden Leaf - 48.12m
Canopy Growth Corp. - 1.3B
Aurora Cannabis Inc. - 740.05m
Aphria Inc. - 502.22m
Harvest One/MMJ entity - 57.14m (estimate)

Harvest One ended up listing with a MC of around 80m from memory. Here's where we stand now.

THC Biomed - 139m
Supreme - 411m
Pharmacan/Cronos - 1.24B
Organigram - 664m
Maple Leaf - 80m
Golden Leaf - 130m
Canopy - 7.86B
Aurora - 5.08B
Aphria - 2.44B
Harvest One - 116m

Since then there are a few more players..

Hydropothecary - 946m
Weed MD - 186m
Cannabis Wheaton - 618m
CannTrust - 858m
Maricann - 237m
AbCann - 272m
TGOD - 1.29B

This is not an exhaustive list but a fair snapshot of the industry. It's pretty clear some have kicked goals and been rewarded ie. WEED, APH, ACB & CRON, and others more favored by investors ie. TGOD.
Can't help but feel that had HVT delivered faster on their expansion plans that we could be sitting closer to the mid caps rather than sitting near the bottom of the ladder still. However having over half our current MC in cash on hand at the moment and some good news on the horizon ie. Satipharm sales in Canada & possible developments such as outdoor growing we have a few catalysts to look forward to.
If management can start to deliver, with some patience this will be a good investment.